AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug

AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug

Submitted by admin on August 8, 2022 - 9:54am
Source: 
Endpoints
News Tags: 
AstraZeneca
Hutchmed
clinical trials
Tagrisso
savolitinib
lung cancer
Headline: 
AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug
snippet: 

In a new data readout exploring a potential Tagrisso combination therapy, AstraZeneca revealed Monday morning that it’s all about the MET.

Do Not Allow Advertisers to Use My Personal information